OKYO.L

OKYO Pharma Limited [OKYO.L] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

OKYO.L Stock Summary

In the News

OKYO.L Financial details

Company Rating
Sell
Market Cap
23.22M
Income
-1.21M
Revenue
0
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
7
Optionable
No
Shortable
Yes
Earnings
14 Aug 2023
P/E
-4.22
Forward P/E
-
PEG
0.9
P/S
-
P/B
7.78
P/C
-
P/FCF
-7.1
Quick Ratio
2.65
Current Ratio
3.17
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0
EPS next Y
-
EPS next Q
-
EPS this Y
-6.67%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-126%
ROE
-136%
ROC
-2.11%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
1.66B
Shs Float
8.54M
-
-
-
-
Target Price
-
52W Range
0.0-8.5
52W High
-
52W Low
-
RSI
-
Rel Volume
0.04
Avg Volume
538.14K
Volume
-
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-
-
-
-
-
Beta
-0.061508
-
-
Volatility
0%, 0%
Prev Close
-
Price
-
Change
-

OKYO.L Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-03-31

Metric History 2018-03-312019-03-312020-03-312021-03-31 2022-03-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
00000
Net income per share
-0.14-0.01000
Operating cash flow per share
00000
Free cash flow per share
00000
Cash per share
0.01000.010
Book value per share
0.01000.010
Tangible book value per share
0.01000.010
Share holders equity per share
0.01000.010
Interest debt per share
00000
Market cap
8.4M6.17M10.12M53.82M63.65M
Enterprise value
6.39M5.69M9.96M48.9M61.59M
P/E ratio
-0.16-1.64-8.34-17.96-15.39
Price to sales ratio
00000
POCF ratio
-8.44-4.04-9.5-43.23-15.29
PFCF ratio
-8.44-4.04-9.5-43.06-15.29
P/B Ratio
4.3824.14-89.5713.9628.37
PTB ratio
4.3824.14-89.5713.9628.37
EV to sales
00000
Enterprise value over EBITDA
-0.12-1.51-8.55-16.32-13.02
EV to operating cash flow
-6.42-3.73-9.35-39.28-14.8
EV to free cash flow
-6.42-3.72-9.35-39.12-14.79
Earnings yield
-6.33-0.61-0.12-0.06-0.06
Free cash flow yield
-0.12-0.25-0.11-0.02-0.07
Debt to equity
00-0.230.020
Debt to assets
000.050.010
Net debt to EBITDA
0.040.130.141.640.43
Current ratio
22.051.780.84.093.17
Interest coverage
00-1.32K-3.5K0
Income quality
0.020.410.840.410.88
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00000
Research and developement to revenue
00000
Intangibles to total assets
00000
Capex to operating cash flow
00000
Capex to revenue
00000
Capex to depreciation
0-6.070-0.5-0.72
Stock based compensation to revenue
00000
Graham number
0.130.0100.020.01
ROIC
-0.44-14.6218.58-0.75-1.84
Return on tangible assets
-26.47-6.45-2.51-0.58-1.26
Graham Net
0.01000.010
Working capital
1.92M254.57K-116.35K3.83M2.24M
Tangible asset value
1.92M255.42K-113.02K3.85M2.24M
Net current asset value
1.92M254.57K-137.81K3.78M2.24M
Invested capital
00-0.230.020
Average receivables
0000336.27K
Average payables
73.69K146.35K386.33K316.42K358.79K
Average inventory
0000-84.89K
Days sales outstanding
00000
Days payables outstanding
00000
Days of inventory on hand
00000
Receivables turnover
00000
Payables turnover
00000
Inventory turnover
00000
ROE
-27.73-14.7210.75-0.78-1.84
Capex per share
00000

Quarterly Fundamentals Overview

Last date of statement is 2022-09-30 for Q2

Metric History 2020-09-302021-03-312021-09-302022-03-31 2022-09-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
00000
Net income per share
00000
Operating cash flow per share
00000
Free cash flow per share
00000
Cash per share
0.010000
Book value per share
0.010000
Tangible book value per share
0.010000
Share holders equity per share
0.010000
Interest debt per share
00000
Market cap
48.82M0000
Enterprise value
43.08M-4.92M-3.79M-2.06M-633.63K
P/E ratio
-40.20000
Price to sales ratio
00000
POCF ratio
-183.280000
PFCF ratio
-183.280000
P/B Ratio
8.880000
PTB ratio
8.880000
EV to sales
00000
Enterprise value over EBITDA
-135.820000
EV to operating cash flow
-161.730000
EV to free cash flow
-161.730000
Earnings yield
-0.010000
Free cash flow yield
-0.010000
Debt to equity
00.020.0200
Debt to assets
00.010.0100
Net debt to EBITDA
18.090000
Current ratio
17.944.098.953.170.83
Interest coverage
-1.32K0000
Income quality
0.880000
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00000
Research and developement to revenue
00000
Intangibles to total assets
00000
Capex to operating cash flow
00000
Capex to revenue
00000
Capex to depreciation
00000
Stock based compensation to revenue
00000
Graham number
0.010000
ROIC
-0.050000
Return on tangible assets
-0.050000
Graham Net
0.010000
Working capital
5.49M3.83M3.65M2.24M-314.71K
Tangible asset value
5.5M3.85M3.68M2.24M-309.68K
Net current asset value
5.47M3.78M3.62M2.24M-314.71K
Invested capital
00.020.0200
Average receivables
00000
Average payables
00000
Average inventory
00000
Days sales outstanding
00000
Days payables outstanding
00000
Days of inventory on hand
00000
Receivables turnover
00000
Payables turnover
00000
Inventory turnover
00000
ROE
-0.060000
Capex per share
00000

OKYO.L Frequently Asked Questions

What is OKYO Pharma Limited stock symbol ?

OKYO Pharma Limited is a GB stock and trading under the symbol OKYO.L

What is OKYO Pharma Limited stock quote today ?

OKYO Pharma Limited stock price is $- today.

Is OKYO Pharma Limited stock public?

Yes, OKYO Pharma Limited is a publicly traded company.

Something similar

Top by Market Cap
Similar Market Cap